Search
Showing results for "1"
Explore some of the frequently asked questions that The C3 Study receives.
The Centre includes researchers at The Kids Research Institute Australia’s Diabetes Research Team and the Diabetes Service at the Perth Children’s Hospital.
News & Events
Helping to relieve diabetes distressThe burden of having T1D is enormous and our researchers are conducting a study trying to understand how we can help relieve diabetes distress.
News & Events
Would you like to test our new exercise app?Our research team have been working with young people with type 1 diabetes to design and develop an app that contains guidelines and advice for what to do when you are being physically active.
Research
Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk indigenous infants (PREV-IX-COMBO)Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living in remote areas of the Northern Territory (NT).
Research
Oral prednisolone in preschool children with virus-associated wheeze: A prospective, randomised, double-blind, placebo-controlled trialPreschool children often have episodes of virus-associated wheeze and assessing efficacy of corticosteroids for paediatric wheeze exacerbations is inconcludsive
Research
Respiratory impedance and bronchodilator responsiveness in healthy children aged 2-13 yearsThere is limited information on changes in FOT outcomes in healthy children beyond the preschool years and the level of bronchodilator responsiveness (BDR)...
This role will be responsible for independently conducting research into the interaction between type 1 diabetes and exercise.
News & Events
Help our kids reach their potentialYou're invited to join the Early Childhood Development and Learning Collaboration on Monday 15 August from 7pm to help every child reach their potential.
Research
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastomaChemotherapy often kills a large fraction of cancer cells but leaves behind a small population of drug-tolerant persister cells. These persister cells survive drug treatments through reversible, non-genetic mechanisms and cause tumour recurrence upon cessation of therapy. Here, we report a drug tolerance mechanism regulated by the germ-cell-specific H3K4 methyltransferase PRDM9.